查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
荷尔蒙替代疗法市场，按疗法、按给药途径、按适应症、按国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1351414

荷尔蒙替代疗法市场，按疗法、按给药途径、按适应症、按国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Hormone Replacement Therapy Market, By Therapy, By Route of Administration, By Indication, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 299 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022年荷尔蒙替代疗法市场规模为2098,032万美元，2023年至2030年复合年增长率为6.2%。

HRT 提供一系列给药方案，包括口服药片、贴片、外用乳膏和注射剂型。儘管如此，接受荷尔蒙替代疗法的决定需要对潜在风险和益处进行彻底评估。个人必须与医疗保健专业人员进行全面讨论，以便就其治疗过程做出明智且个性化的选择。

荷尔蒙替代疗法市场 - 市场动态：

  • 缓解更年期症状、提高女性生活品质的愿望推动市场需求
  • 更年期相关不适的影响包括潮热、情绪波动和骨骼健康问题等，可能会严重干扰日常生活。荷尔蒙替代疗法（HRT）成为一种有价值的解决方案，透过恢復荷尔蒙水平、减轻症状和缓解相关不适来应对这些挑战。这促使许多女性将荷尔蒙替代疗法视为在人生过渡阶段恢復舒适和整体健康的一种手段。对女性健康赋权的日益重视，加上对荷尔蒙替代疗法潜在益处的认识不断增强，有助于这种疗法的持续流行。

荷尔蒙替代疗法市场 - 主要见解：

  • 全球荷尔蒙替代疗法市场根据疗法、给药途径和地区进行分类。
  • 该市场根据治疗方法分为多种类别，包括雌激素替代品、生长激素替代品、甲状腺激素替代品和睪固酮激素替代品。其中，雌激素替代品在 2022 年占据最大的市场份额。
  • 就给药途径而言，市场分为口服、肠外和经皮给药。肠外给药是 2022 年的主要给药途径。
  • 就地区而言，亚太地区将成为 2022 年主要的收入来源。

荷尔蒙替代疗法市场-細項分析：

  • 全球荷尔蒙替代疗法市场根据疗法、给药途径、适应症和地区进行细分。
  • 该市场由各种治疗类别组成，包括雌激素替代品、生长激素替代品、甲状腺激素替代品和睪固酮替代品。其中，雌激素替代品率先占领市场。雌激素替代疗法 (HRT) 因其在解决潮热、阴道干燥和骨骼健康问题等更年期症状方面的有效性而持续受欢迎。女性越来越多地转向雌激素 HRT 来提高更年期过渡期间的整体生活质量，这使其作为首选治疗选择的持续突出。

荷尔蒙替代疗法市场-竞争格局：

目前，荷尔蒙替代疗法（HRT）的竞争格局由诺华、辉瑞、礼来等主要製药巨头占据主导地位。这些行业领导者利用其广泛的研究能力和良好的品牌知名度，提供一系列荷尔蒙产品，同时享有广泛的市场份额。

此外，该市场还包括 TherapeuticsMD 和 Mithra Pharmaceuticals 等规模较小的专业公司，它们专注于开发利基配方以满足特定的医疗保健需求。 HRT 市场内的竞争受到治疗效果、安全性考量、给药方法和病患偏好等因素的影响。预计对个人化医疗保健解决方案的需求不断增长，优先开发创新、耐受性良好且用户友好的 HRT 方案的公司可能会在这个不断发展的市场中获得竞争优势。

目录

第一章：荷尔蒙替代疗法市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 荷尔蒙替代疗法市场片段（按疗法）
    • 依给药途径分類的荷尔蒙替代疗法市场片段
    • 按适应症分類的荷尔蒙替代疗法市场片段
    • 按国家/地区分類的荷尔蒙替代疗法市场片段
    • 按地区分類的荷尔蒙替代疗法市场片段
  • 竞争洞察

第 3 章：荷尔蒙替代疗法主要市场趋势

  • 荷尔蒙替代疗法市场驱动因素
    • 市场驱动因素的影响分析
  • 荷尔蒙替代疗法市场限制
    • 市场限制影响分析
  • 荷尔蒙替代疗法的市场机会
  • 荷尔蒙替代疗法市场未来趋势

第 4 章：荷尔蒙替代疗法产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：荷尔蒙替代疗法市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：荷尔蒙替代疗法市场格局

  • 2022 年荷尔蒙替代疗法市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：荷尔蒙替代疗法市场 - 按疗法

  • 概述
    • 按疗法分類的细分市场份额分析
    • 雌激素替代品
    • 生长激素替代品
    • 甲状腺激素替代疗法
    • 睾酮替代品

第 8 章：荷尔蒙替代疗法市场 - 按给药途径

  • 概述
    • 按给药途径分類的细分市占率分析
    • 口服
    • 注射用
    • 其他给药途径

第 9 章：荷尔蒙替代疗法市场 - 按适应症

  • 概述
    • 按指标分類的细分市场占有率分析
    • 停经
    • 甲状腺功能低下症
    • 生长激素缺乏
    • 其他适应症

第 10 章：荷尔蒙替代疗法市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美荷尔蒙替代疗法主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按治疗）
    • 北美市场规模与预测（按管理途径）
    • 北美市场规模和预测（按指标）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲荷尔蒙替代疗法主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按治疗）
    • 欧洲市场规模与预测（按管理途径）
    • 欧洲市场规模与预测（按指标）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区荷尔蒙替代疗法主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按治疗）
    • 亚太地区市场规模与预测（依管理途径）
    • 亚太地区市场规模与预测（依指标）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲荷尔蒙替代疗法主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按疗法）
    • 拉丁美洲市场规模与预测（按管理途径）
    • 拉丁美洲市场规模与预测（按指标）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲激素替代疗法主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模和预测（按疗法）
    • 中东和非洲市场规模及预测（按管理途径）
    • 中东和非洲市场规模及预测（依指标）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 荷尔蒙替代疗法产业

  • 竞争仪表板
  • 公司简介
    • Novartis Pharmaceuticals
    • Pfizer Inc.
    • Eli Lilly and Company
    • Bayer AG
    • AbbVie Inc.
    • Merck & Co., Inc.
    • Amgen Inc.
    • TherapeuticsMD, Inc.
    • Allergan plc
    • Mylan NV
    • Teva Pharmaceutical Industries Ltd.
    • Glenmark Pharmaceuticals
    • Mithra Pharmaceuticals
    • Noven Pharmaceuticals
    • Besins Healthcare

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV1662

REPORT HIGHLIGHT

Hormone Replacement Therapy Market size was valued at USD 20,980.32 Million in 2022, expanding at a CAGR of 6.2% from 2023 to 2030.

Hormone Replacement Therapy (HRT) is a medical intervention aimed at restoring hormonal equilibrium in individuals experiencing hormonal deficiencies or imbalances. This therapy can involve the use of synthetic or naturally occurring hormones, such as estrogen, progesterone, or a combination of both. It is commonly employed to alleviate symptoms associated with menopause or specific medical conditions. The primary objective of HRT is to mitigate discomforting symptoms like hot flashes, mood swings, and the loss of bone density.

HRT offers a range of administration options, including oral tablets, patches, topical creams, and injectable formulations. Nonetheless, the decision to undergo HRT necessitates a thorough evaluation of potential risks and benefits. It is essential for individuals to engage in comprehensive discussions with healthcare professionals to make well-informed and personalized choices regarding their treatment journey.

Hormone Replacement Therapy Market - Market Dynamics:

  • Desire to alleviate menopausal symptoms and enhance quality of life for women to propel market demand
  • The impact of menopause-related discomforts, which can encompass issues like hot flashes, mood swings, and bone health concerns, can significantly disrupt daily life. Hormone Replacement Therapy (HRT) emerges as a valuable solution for addressing these challenges by restoring hormone levels, reducing symptoms, and easing associated discomfort. This prompts many women to consider HRT as a means of regaining comfort and overall well-being during this transitional phase of life. The increasing emphasis on women's health empowerment, coupled with a growing awareness of the potential benefits of HRT, contributes to the sustained popularity of this therapy.

Hormone Replacement Therapy Market - Key Insights:

  • The Global Hormone Replacement Therapy Market is categorized based on Therapy, Route of Administration, and Region.
  • This market is divided into various categories depending on Therapy, including Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, and Testosterone Hormone Replacement. Among these, Estrogen Hormone Replacement held the largest market share in 2022.
  • In terms of Route of Administration, the market is segmented into Oral, Parenteral, and Transdermal. Parenteral was the leading route of administration in 2022.
  • When it comes to regions, Asia Pacific emerged as the leading revenue generator in 2022.

Hormone Replacement Therapy Market- Segmentation Analysis:

  • The Global Hormone Replacement Therapy Market is segmented based on Therapy, Route of Administration, Indication, and Region.
  • The market consists of various Therapy categories, including Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, and Testosterone Replacement. Among these categories, Estrogen Hormone Replacement takes the lead in dominating the market. The popularity of Estrogen Hormone Replacement Therapy (HRT) persists due to its effectiveness in addressing menopausal symptoms like hot flashes, vaginal dryness, and bone health concerns. Women increasingly turn to Estrogen HRT to enhance their overall quality of life during the menopausal transition, contributing to its sustained prominence as a preferred therapeutic option.

Hormone Replacement Therapy Market- Competitive Landscape:

The competitive landscape of Hormone Replacement Therapy (HRT) is currently marked by the dominance of major pharmaceutical giants like Novartis, Pfizer, and Eli Lilly. These industry leaders leverage their extensive research capabilities and well-established brand recognition to offer a range of hormone products while enjoying a wide market presence.

Moreover, the market includes smaller, specialized companies such as TherapeuticsMD and Mithra Pharmaceuticals, which focus on developing niche formulations to cater to specific healthcare needs. Competition within the HRT market is influenced by factors like treatment effectiveness, safety considerations, administration methods, and patient preferences. In anticipation of the growing demand for personalized healthcare solutions, companies that prioritize the development of innovative, well-tolerated, and user-friendly HRT options are likely to gain a competitive edge in this evolving market.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HORMONE REPLACEMENT THERAPY MARKET KEY PLAYERS

  • Novartis Pharmaceuticals
  • Pfizer Inc.
  • Eli Lilly and Company
  • Bayer AG
  • AbbVie Inc.
  • Merck & Co., Inc.
  • Amgen Inc.
  • TherapeuticsMD, Inc.
  • Allergan plc
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Glenmark Pharmaceuticals
  • Mithra Pharmaceuticals
  • Noven Pharmaceuticals
  • Besins Healthcare

GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY

  • Estrogen Hormone Replacement
  • Growth Hormone Replacement
  • Thyroid Hormone Replacement
  • Testosterone Replacement

GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION

  • Oral
  • Parenteral
  • Other Routes of Administration

GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY INDICATION

  • Menopause
  • Hypothyroidism
  • Growth Hormone Deficiency
  • Other Indications

GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Hormone Replacement Therapy Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Hormone Replacement Therapy Market Snippet by Therapy
    • 2.1.2. Hormone Replacement Therapy Market Snippet by Route of Administration
    • 2.1.3. Hormone Replacement Therapy Market Snippet by Indication
    • 2.1.4. Hormone Replacement Therapy Market Snippet by Country
    • 2.1.5. Hormone Replacement Therapy Market Snippet by Region
  • 2.2. Competitive Insights

3. Hormone Replacement Therapy Key Market Trends

  • 3.1. Hormone Replacement Therapy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Hormone Replacement Therapy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Hormone Replacement Therapy Market Opportunities
  • 3.4. Hormone Replacement Therapy Market Future Trends

4. Hormone Replacement Therapy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Hormone Replacement Therapy Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Hormone Replacement Therapy Market Landscape

  • 6.1. Hormone Replacement Therapy Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Hormone Replacement Therapy Market - By Therapy

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Therapy, 2022 & 2030 (%)
    • 7.1.2. Estrogen Hormone Replacement
    • 7.1.3. Growth Hormone Replacement
    • 7.1.4. Thyroid Hormone Replacement
    • 7.1.5. Testosterone Replacement

8. Hormone Replacement Therapy Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
    • 8.1.2. Oral
    • 8.1.3. Parenteral
    • 8.1.4. Other Routes of Administration

9. Hormone Replacement Therapy Market - By Indication

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
    • 9.1.2. Menopause
    • 9.1.3. Hypothyroidism
    • 9.1.4. Growth Hormone Deficiency
    • 9.1.5. Other Indications

10. Hormone Replacement Therapy Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Hormone Replacement Therapy Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Hormone Replacement Therapy Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Hormone Replacement Therapy Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Hormone Replacement Therapy Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Hormone Replacement Therapy Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Hormone Replacement Therapy Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Novartis Pharmaceuticals
    • 11.2.2. Pfizer Inc.
    • 11.2.3. Eli Lilly and Company
    • 11.2.4. Bayer AG
    • 11.2.5. AbbVie Inc.
    • 11.2.6. Merck & Co., Inc.
    • 11.2.7. Amgen Inc.
    • 11.2.8. TherapeuticsMD, Inc.
    • 11.2.9. Allergan plc
    • 11.2.10. Mylan N.V.
    • 11.2.11. Teva Pharmaceutical Industries Ltd.
    • 11.2.12. Glenmark Pharmaceuticals
    • 11.2.13. Mithra Pharmaceuticals
    • 11.2.14. Noven Pharmaceuticals
    • 11.2.15. Besins Healthcare

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Hormone Replacement Therapy Market: Therapy Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Therapy
  • TABLE Global Hormone Replacement Therapy Market, by Therapy 2018-2030 (USD Million)
  • TABLE Hormone Replacement Therapy Market: Route of Administration Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Hormone Replacement Therapy Market, by Route of Administration 2018-2030 (USD Million)
  • TABLE Hormone Replacement Therapy Market: Indication Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Hormone Replacement Therapy Market, by Indication 2018-2030 (USD Million)
  • TABLE Hormone Replacement Therapy Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Hormone Replacement Therapy Market, by Region 2018-2030 (USD Million)
  • TABLE North America Hormone Replacement Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Hormone Replacement Therapy Market, by Therapy, 2018-2030 (USD Million)
  • TABLE North America Hormone Replacement Therapy Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE North America Hormone Replacement Therapy Market, by Indication, 2018-2030 (USD Million)
  • TABLE Europe Hormone Replacement Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Hormone Replacement Therapy Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Europe Hormone Replacement Therapy Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe Hormone Replacement Therapy Market, by Indication, 2018-2030 (USD Million)
  • TABLE Asia Pacific Hormone Replacement Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Hormone Replacement Therapy Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Asia Pacific Hormone Replacement Therapy Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific Hormone Replacement Therapy Market, by Indication, 2018-2030 (USD Million)
  • TABLE Latin America Hormone Replacement Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Hormone Replacement Therapy Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Latin America Hormone Replacement Therapy Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America Hormone Replacement Therapy Market, by Indication, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Hormone Replacement Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Hormone Replacement Therapy Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Hormone Replacement Therapy Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Hormone Replacement Therapy Market, by Indication, 2018-2030 (USD Million)